Advertisement
Advertisement
U.S. markets close in 1 hour 8 minutes
Advertisement
Advertisement
Advertisement
Advertisement

IRLAB Therapeutics AB (6IRA.BE)

Berlin - Berlin Delayed Price. Currency in EUR
0.6140+0.0120 (+1.99%)
As of 08:20PM CEST. Market open.
Advertisement
Advertisement
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
35,554
61,136
207,782
0
26
Cost of Revenue
-
0
39,091
-
-
Gross Profit
-
61,136
168,691
-
-
Operating Expense
196,939
174,245
116,115
91,458
95,948
Operating Income
-161,385
-113,109
52,576
-91,458
-95,922
Net Non Operating Interest Income Expense
-197
-297
-369
-194
-272
Pretax Income
-161,582
-113,406
51,781
-91,653
-96,120
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
-161,582
-113,406
51,781
-91,653
-96,120
Diluted NI Available to Com Stockholders
-161,582
-113,406
51,781
-91,653
-96,120
Basic EPS
-
-2.19
1.00
-1.92
-2.37
Diluted EPS
-
-2.19
1.00
-1.92
-2.37
Basic Average Shares
-
51,832
51,748
47,678
40,593
Diluted Average Shares
-
51,832
51,748
47,678
40,593
Total Operating Income as Reported
-161,386
-113,110
52,576
-91,458
-95,848
Total Expenses
196,939
174,245
155,206
91,458
95,948
Net Income from Continuing & Discontinued Operation
-161,582
-113,406
51,781
-91,653
-96,120
Normalized Income
-161,582
-113,406
51,781
-91,653
-96,194
Interest Income
7
0
1
1
0
Interest Expense
204
297
370
195
272
Net Interest Income
-197
-297
-369
-194
-272
EBIT
-161,378
-113,109
52,151
-91,458
-95,848
EBITDA
-156,337
-108,330
55,625
-89,202
-92,916
Reconciled Cost of Revenue
-
0
39,091
-
-
Reconciled Depreciation
5,041
3,982
3,474
2,256
2,932
Net Income from Continuing Operation Net Minority Interest
-161,582
-113,406
51,781
-91,653
-96,120
Total Unusual Items Excluding Goodwill
-
-
-39,091
0
74
Total Unusual Items
-
-
-39,091
0
74
Normalized EBITDA
-156,337
-108,330
55,625
-89,202
-92,990
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
Advertisement
Advertisement